Kai-Xin-San ameliorates Alzheimer's disease-related neuropathology and cognitive impairment in APP/PS1 mice via the mitochondrial autophagy-NLRP3 inflammasome pathway

Apr 6, 2024Journal of ethnopharmacology

Kai-Xin-San reduces Alzheimer's brain damage and memory loss in mice by improving mitochondrial cleanup and lowering inflammation

AI simplified

Abstract

KXS significantly enhanced spatial learning and memory capacities in AD mice.

  • KXS reversed abnormal biochemical index levels and reduced amyloid-β protein deposition in the brains of AD mice.
  • Neuronal damage in AD mice was remarkably improved after KXS treatment, as shown by H&E staining.
  • Mitochondrial damage in microglia was ameliorated by KXS, promoting mitochondrial autophagy.
  • KXS increased the expression of proteins related to autophagy and confirmed mitochondrial autophagy in microglia.
  • The treatment enhanced the PINK1/Parkin pathway while reducing the activation of the NLRP3 inflammasome.
  • The beneficial effects of KXS were diminished by the mitochondrial autophagy inhibitor chloroquine.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free